Doctor profile · Federal record
Dr. JALAL DAMANI, DO
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · CHICAGO, IL
- NPI 1477946994
- Accepts Medicare
- MIPS 90.4 / 100 · 2023
- 11 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5140 N CALIFORNIA AVE
CHICAGO, IL 606253645
(773) 989-1257
fax (847) 763-8915
Credentials & registration
- NPI registered
- March 2015 — 11 yrs on file
- Profile last updated
- July 29, 2022
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Illinois #036145694
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477946994. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
894
Distinct HCPCS
10
Medicare allowed
$122,184
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 137 | 87 | $125 | |
99291 |
Critical care, first 30-74 minutes | 105 | 52 | $225 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 90 | 45 | $187 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 76 | 58 | $133 | |
31645 |
Aspiration of initial secretion of lung airway using an endoscope | 51 | 49 | $59 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 47 | 47 | $182 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 43 | 36 | $83 | |
31628 |
Biopsy of lobe of lung using an endoscope, 1 lobe | 40 | 39 | $57 | |
31654 |
Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 37 | 37 | $69 | |
31627 |
Computer-assisted image-guided navigation of lung airways using an endoscope | 34 | 34 | $101 |
In context: peer comparison
Among 66 peers in this city , average services per provider: 90. This provider delivers 9.9× the peer median.Open Payments
Industry payments received
All-time total
$1,424
Transactions
33
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | 5 | $763.60 | |
| GENZYME CORPORATION | 5 | $149.73 | |
| AstraZeneca Pharmaceuticals LP | 4 | $85.34 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $65.16 | |
| Merck Sharp & Dohme LLC | 2 | $64.15 | |
| Electromed, Inc. | 5 | $59.84 | |
| GlaxoSmithKline, LLC. | 2 | $55.32 | |
| Insmed, Inc. | 2 | $42.20 | |
| Pinnacle Biologics, Inc | 2 | $35.37 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34.53 | |
| Philips North America LLC | 1 | $31.01 | |
| Pulmonx Corporation | 1 | $19.42 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,019
Patients
295
Total drug cost
$640,486
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 143 | 35 | $119,191 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 97 | 34 | $3,829 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 92 | 16 | $48,176 |
| Prednisone | Generic | 87 | 35 | $369 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 83 | 23 | $53,119 |
| Pantoprazole Sodium | Generic | 80 | 26 | $1,158 |
| Azithromycin | Generic | 74 | 27 | $1,642 |
| Montelukast Sodium | Generic | 73 | 24 | $1,370 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 60 | 15 | $30,384 |
| Azelastine Hcl | Generic | 51 | 12 | $1,797 |